16-Provincial Alliance Announces Results of Coronary Interventional Balloon Bulk Procurement

Medical Procurement Information Express

Professional Information Service Platform in the Field of Medical Device Procurement!

Source: Medical Device Dealers Alliance Organization

On April 16, the Henan Province Pharmaceutical Centralized Procurement Platform released the "Public Announcement of the Winning Results of the Provincial Alliance's Centralized Volume-based Procurement of Coronary Intervention Balloon-Type Medical Consumables" (hereinafter referred to as the "Winning Results").

The procurement items this time areCoronary Cutting, Scoring, Spur, and Papillary Balloons, led by Henan, covering Tianjin, Shanxi, Inner Mongolia, Jilin, Heilongjiang, Shanghai, Fujian, Hubei, Hunan, Hainan, Chongqing, Sichuan, Shaanxi, Gansu, and Ningxia, etc.16 Provinces, Procurement Cycle2Year.

In terms of reductionAlthough the final winning bid prices have not been fully announced, the quotations from the proposed winning companies generally fall within a reasonable range, with some products showing moderate price reductions. For instance,DK Medtech's scored balloon proposed winning bid price is 2046 RMB, representing a mere 0.97% decrease compared to the anchor price of 2066 RMB., reflecting rational pricing under the "anti-involution" orientation.

The design of the centralized procurement rules also emphasizes avoiding malicious price reductions by adopting an "anchor price" mechanism (taking the higher value between "the average valid bidding price minus one standard deviation" and "the lowest valid bidding price") and setting multiple rounds of bidding thresholds to ensure price stability.

According to the procurement rules, enterprises selected under Rule One will directly receive 100% of their committed procurement volume.Rule Three Intended Winning Enterprises, among which only40%It is a fixed amount directly allocated by the alliance, and the remaining 60% depends on the independent selection of medical institutions. Meanwhile,The number of enterprises selected under the third rule is not small.

In terms of demand and enterprise distribution,The pattern dominated by foreign investment remains unshaken.In the cutting balloon market, Boston Scientific and Lepu Medical dominate the majority of demand; in categories like scoring balloons and papillary balloons, foreign companies still hold a significant advantage, with the market being highly concentrated.

ButThe signal for domestic substitution is becoming increasingly clear.With the boost from centralized procurement, domestic brands such as BrosMed Medical, DK Medtech, Shanghai MicroPort Melody, and Sino Medical are gaining even more momentum. The first wave of market reshuffling is here!

The winning results are as follows: